Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1997-6-4
|
pubmed:abstractText |
We used transgenic mice expressing a dominant negative mutation of interleukin-1 beta converting enzyme (ICE) (C285G) in a model of transient focal ischemia in order to investigate the role of ICE in ischemic brain damage. Transgenic mutant ICE mice (n = 11) and wild-type littermates (n = 9) were subjected to 3 h of middle cerebral artery occlusion followed by 24 h of reperfusion. Cerebral infarcts and brain swelling were reduced by 44% and 46%, respectively. Neurological deficits were also significantly reduced. Regional CBF, blood pressure, core temperature, and heart rate did not differ between groups when measured for up to 1 h after reperfusion. Increases in immunoreactive IL-1 beta levels, observed in ischemic wild-type brain at 30 min after reperfusion, were 77% lower in the mutant strain, indicating that proIL-1 beta cleavage is inhibited in the mutants. DNA fragmentation was reduced in the mutants 6 and 24 h after reperfusion. Hence, endogenous expression of an ICE inhibitor confers resistance to cerebral ischemia and brain swelling. Our results indicate that downregulation of ICE expression might provide a useful therapeutic target in cerebral ischemia.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0271-678X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
370-5
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:9143219-Animals,
pubmed-meshheading:9143219-Brain,
pubmed-meshheading:9143219-Brain Ischemia,
pubmed-meshheading:9143219-Caspase 1,
pubmed-meshheading:9143219-Cerebral Infarction,
pubmed-meshheading:9143219-Cerebrovascular Circulation,
pubmed-meshheading:9143219-Cysteine Endopeptidases,
pubmed-meshheading:9143219-DNA Fragmentation,
pubmed-meshheading:9143219-Gene Expression,
pubmed-meshheading:9143219-Interleukin-1,
pubmed-meshheading:9143219-Mice,
pubmed-meshheading:9143219-Mice, Transgenic,
pubmed-meshheading:9143219-Mutation,
pubmed-meshheading:9143219-Nervous System Diseases
|
pubmed:year |
1997
|
pubmed:articleTitle |
Attenuation of transient focal cerebral ischemic injury in transgenic mice expressing a mutant ICE inhibitory protein.
|
pubmed:affiliation |
Stroke and Neurovascular Regulation, Neurosurgical Service, Massachusetts General Hospital, Harvard Medical School, Charlestown 02129, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|